Novel method for studying myelination in vivo reveals that EDTA is a potent inhibitor of myelin protein and mRNA expression during development of the rat sciatic nerve

GLIA

Volumn 48, Issue 2, 2004, Pages 132-144

  Meintanis, Stathis ^a   Thomaidou, Dimitra ^a   Jessen, Kristjan R ^a   Mirsky, Rhona ^b   Matsas, Rebecca ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Electron microscopy; Nerve surgery; Schwann cells; Silicon implants; Transcription factor

Indexed keywords

CALCIUM ION; EDETIC ACID; GALACTOSYLCERAMIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; MAGNESIUM ION; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN ASSOCIATED MOLECULE PROTEIN P0; MYELIN BASIC PROTEIN; MYELIN PROTEIN; NEUROFILAMENT PROTEIN; SILASTIC; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KROX 20; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; IN SITU HYBRIDIZATION; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE GROWTH; NEUROFILAMENT; NEUROMUSCULAR SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SCIATIC NERVE;

ANIMALS; ANIMALS, NEWBORN; CHELATING AGENTS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG CARRIERS; EARLY GROWTH RESPONSE PROTEIN 2; EDETIC ACID; GALACTOSYLCERAMIDES; GROWTH INHIBITORS; IMPLANTS, EXPERIMENTAL; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN BASIC PROTEINS; MYELIN P0 PROTEIN; MYELIN PROTEINS; MYELIN SHEATH; NERVE REGENERATION; NEUROSURGICAL PROCEDURES; RATS; RNA, MESSENGER; SCHWANN CELLS; SCIATIC NERVE; SILICONE ELASTOMERS; TRANSCRIPTION FACTORS;

EID: 9144256230     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20064     Document Type: Article

References (48)

1. Bermingham JR Jr, Scherer SS, O'Connell S, Arroyo E, Kalla KA, Powell FL, Rosenfeld MG. 1996. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev 10:1751-1762.
2. Blanchard AD, Sinanan A, Parmantier E, Zwart R, Broos L, Meijer D, Meier C, Jessen KR, Mirsky R. 1996. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res 46:630-640.
3. Bosio A, Binczek E, Stoffel W. 1996. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci USA 93:13280-13285.
4. Connold AL, Greensmith L, Tyc F, Vrbova G. 1997. A simple method for local delivery of various substances to the rat neuromuscular system. Brain Res Brain Res Protoc 1:79-82.
5. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR. 1995. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15:585-596.
6. Dowsing BJ, Morrison WA, Nicola NA, Starkey GP, Bucci T, Kilpatrick TJ. 1999. Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. Neurochem 73:96-104.
7. Fruttiger M, Montag D, Schachner M, Martini R. 1995. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 7:511-515.
8. Fulcher IS, Matsas R, Turner AJ, Kenny AJ. 1982. Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitors. Biochem J 203:519-522.
9. Garratt AN, Britsch S, Birchmeier C. 2000. Neuregulin, a factor with many functions in the life of a Schwann cell. BioEssays 22:987-996.
10. Ghislain J, Desmarquet-Trin-Dinh C, Jaegle M, Meijer D, Charnay P, Frain M. 2002. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129:155-166.
11. Ghislain J, Desmarquet-Trin-Dinh C, Gilardi-Hebenstreit P, Charnay P, Frain M. 2003. Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control. Development 130:941-953.
12. Giese KP, Martini R, Lemke G, Soriano P, Schachner M. 1992. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576.
13. Griffiths IR, McCulloch MC, Barrie JA, Kyriakides E. 1991. Expression of P0 mRNA in myelinating Schwann cells is related to fibre size. J Neurocytol 20:396-394.
14. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS. 1996. Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
15. Indig FE, Ben Meir D, Spungin A, Blumberg S. 1989. Investigation of neutral endopeptidases (EC 3.4.24.11) and of neutral proteinases (EC 3.4.24.4) using a new sensitive two-stage enzymatic reaction. FEBS Lett 255:237-240.
16. Jaegle M, Meijer D. 1998. Role of Oct-6 in Schwann cell differentiation. Microsc Res Tech 41:372-378.
17. Jaegle M, Mandemakers W, Broos L, Zwart R, Karis A, Visser P, Grosveld F, Meijer D. 1996. The POU factor Oct-6 and Schwann cell differentiation. Science 273:507-510.
18. Jaegle M, Ghazvini M, Mandemakers W, Piirsoo M, Driegen S, Levavasseur F, Raghoenath S, Grosveld F, Meijer D. 2003. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes Dev 17:1380-1391.
19. Jessen KR, Mirsky R. 1999. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22:402-410.
20. Kioussi C, Crine P, Matsas R. 1992. Endopeptidase-24.11 is suppressed in myelin-forming but not in non-myelin-forming Schwann cells during development of the rat sciatic nerve. Neuroscience 50:69-83.
21. Kioussi C, Gross MK, Gruss P. 1995. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15:553-562.
22. Lee M, Brennan A, Blanchard A, Zoidl G, Dong Z, Tabernero A, Zoidl C, Dent MA, Jessen KR, Mirsky R. 1997. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol Cell Neurosci 8:336-350.
23. Mahanthappa NK, Anton ES, Matthew WD. 1996. Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. J Neurosci 16:4673-4683.
24. Martini R, Schachner M. 1986. Immunoelectron microscopic localisation of neural cell adhesion molecules (LI, NCAM and MAG) and their shared carboxhydrate epitope and myelin basic protein (MBP) in developing sciatic nerve. J Cell Biol 103:2439-2448.
25. Martini R, Schachner M. 1997. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules. Glia 19:298-310.
26. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. 1995. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 11:281-286.
27. Matsas R, Fulcher IS, Kenny AJ, Turner AJ. 1983. Substance P and [Leu] enkephalin are hydrolysed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 80:3111-3115.
28. Maurel P, Sodzer JL. 2000. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI3-kinase activity. J Neurosci 20:4535-4645.
29. Meier C, Parmantier E, Brennan A, Mirsky R, Jessen KR. 1999. Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci 19:3847-3859.
30. Meintanis S, Thomaidou D, Jessen KR, Mirsky R, Matsas R. 2001. The neuron-glia signal β-Neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34:39-51.
31. Meyer D, Birchmeier C. 1995. Multiple essential functions of neuregulin in development. Nature 23:386-390.
32. Mirsky R, Jessen KR. 1990. Schwann cell development and the regulation of myelination. Semin Neurosci 2:423-435.
33. Mirsky R, Jessen KR, Schachner M, Goridis C. 1986. Distribution of the adhesion molecules N-CAM and LI on peripheral neurons and glia in adult rats. J Neurocytol 15:799-815.
34. Morrissey TK, Kleitman N, Bunge RP. 1995. Human Schwann cells in vitro. Myelination of sensory axons following extensive purification and heregulin-induced expansion. II. J Neurobiol 28:190-201.
35. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Huffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, [Su JL, et al. 1997]. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736.
36. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van Evercooren A, Charnay P. 1996. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122:2847-2857.
37. Nickols JC, Valentine W, Kanwal S, Carter BD. 2003. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 6:161-167.
38. Roques BP, Beaumont A. 1990. Neutral endopeptidase-24.11 inhibitors: from analgesic to antihypertensives? Trends Pharmacol Sci 2:245-249.
39. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ. 1994. Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77:349-360.
40. Spencer-Dene B, Thorogood P, Nair S, Kenny AJ, Harris M. 1994. Distribution of, and a putative role for, the cell surface neutral metalloendopeptidases during mammalian craniofacial development. Development 120:3213-3226.
41. Spungin A, Blumberg S. 1989. Streptomyces griseus aminopeptidase is a calcium-activated zinc metalloprotein. Purification and properties of the enzyme. Eur J Biochem 183:471-477.
42. Swiatek PJ, Gridley T. 1993. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev 7:2071-2084.
43. Syroid DE, Zorick TS, Arbet-Engels C, Kilpatrick TJ, Eckhart W, Lemke G. 1999. A role for insulin-like growth factor-I in the regulation of Schwann cell survival. J Neurosci 19:2059-2068.
44. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371: 796-799.
45. Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, Mancardi G, Charnay P. 1997. Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res 50:702-712.
46. Weinstein DE, Burrola PG, Lemke G. 1993. Premature Schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol Cell Neurosci 6:212-229.
47. Weiner JA, Chun J. 1999) Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc Natl Acad Sci USA 96:5233-5238.
48. Wolpowitz D, Mason TB, Dietrich P, Mendelsohn M, Talm DA, Role LW. 2000. Cysteine-rich domain isoforms of the neuregulin-1 are required for maintenance of peripheral synapses. Neuron 25:79-91.